Mariela Medina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mariela Medina has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Manuel Francisco Ugarte-Gil
Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru
3 shared publications - Rocío-V. Gamboa-Cárdenas
Servicio de Reumatología, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Av. Miguel Grau 800, La Victoria, 15033, Lima, Peru.
3 shared publications - Cesar A. Pastor-Asurza
Department of Rheumatology, Hospital Nacional Guillermo Almenara Irigoyen, Perú
2 shared publications - Claudia Elera-Fitzcarrald
Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru
2 shared publications - Cristina Reátegui-Sokolova
Rheumatology Department, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Peru
2 shared publications - Graciela S. Alarcon
The University of Alabama at Birmingham
2 shared publications
Latest Publications
- Open Access
- 30 April 2023
- Published by Universidad de Montemorelos in RIEE | Revista Internacional de Estudios en Educación
- Vol. 23 (1) , 1-16
Un estudio de segmentación con estudiantes según su estilo de vida como consumidores de un servicio educativo universitario
En el diseño de estrategias de marketing, una de sus actividades más importantes es la identificación de las características de consumo de los clientes. Esta investigación tuvo como propósito identificar los estilos de vida de acuerdo con los patrones de consumo de los estudiantes de una universidad privada del noreste de México. Con base en un esquema de muestreo no probabilístico por cuotas, se obtuvo la información de 754 estudiantes de nivel pregrado, utilizando un instrumento creado a propósito de este estudio. Los resultados de un análisis factorial exploratorio permitieron la identificación de cuatro estilos: visionario, esforzado, cómodo e inconforme. Esta clasificación podría ser útil para enriquecer el tipo de segmentación psicográfica y diseñar estrategias de marketing orientadas a públicos específicos.
- 30 April 2023
- Published by Universidad de Montemorelos in RIEE | Revista Internacional de Estudios en Educación
- Vol. 23 (1) , 1-16
Open AccessUn estudio de segmentación con estudiantes según su estilo de vida como consumidores de un servicio educativo universitario
En el diseño de estrategias de marketing, una de sus actividades más importantes es la identificación de las características de consumo de los clientes. Esta investigación tuvo como propósito identificar los estilos de vida de acuerdo con los patrones de consumo de los estudiantes de una universidad privada del noreste de México. Con base en un esquema de muestreo no probabilístico por cuotas, se obtuvo la información de 754 estudiantes de nivel pregrado, utilizando un instrumento creado a propósito de este estudio. Los resultados de un análisis factorial exploratorio permitieron la identificación de cuatro estilos: visionario, esforzado, cómodo e inconforme. Esta clasificación podría ser útil para enriquecer el tipo de segmentación psicográfica y diseñar estrategias de marketing orientadas a públicos específicos.
- 6 January 2022
- Published by SAGE Publications in Lupus
- Vol. 31 (1) , 105-109
Metabolic syndrome predicts new damage in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort
This study aims to determine whether the MetS predicts damage accrual in SLE patients. This longitudinal study was conducted in a cohort of consecutive SLE patients seen since 2012 at one single Peruvian institution. Patients had a baseline visit and then follow-up visits every 6 months. Patients with ≥ 2 visits were included. Evaluations included interview, medical records review, physical examination, and laboratory tests. Damage accrual was ascertained with the SLICC/ACR damage index (SDI) and disease activity with the SLEDAI-2K. Univariable and multivariable Cox-regression survival models were carried out to determine the risk of developing new damage. The multivariable model was adjusted for age at diagnosis; disease duration; socioeconomic status; SLEDAI; baseline SDI; the Charlson Comorbidity Index; daily dose; and time of exposure of prednisone (PDN), antimalarials, and immunosuppressive drugs. Two hundred and forty-nine patients were evaluated; 232 of them were women (93.2%). Their mean (SD) age at diagnosis was 35.8 (13.1) years; nearly all patients were Mestizo. Disease duration was 7.4 (6.6) years. The SLEDAI-2K was 5.2 (4.3) and the SDI, 0.9 (1.3). One hundred and eight patients (43.4%) had MetS at baseline. During follow-up, 116 (46.6%) patients accrued at least one new point in the SDI damage index. In multivariable analyses, the presence of MetS was a predictor of the development of new damage (HR: 1.54 (1.05–2.26); p < 0.029). The presence of MetS predicts the development of new damage in SLE patients, despite other well-known risk factors for such occurrence.
- 6 January 2022
- Published by SAGE Publications in Lupus
- Vol. 31 (1) , 105-109
Metabolic syndrome predicts new damage in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort
This study aims to determine whether the MetS predicts damage accrual in SLE patients. This longitudinal study was conducted in a cohort of consecutive SLE patients seen since 2012 at one single Peruvian institution. Patients had a baseline visit and then follow-up visits every 6 months. Patients with ≥ 2 visits were included. Evaluations included interview, medical records review, physical examination, and laboratory tests. Damage accrual was ascertained with the SLICC/ACR damage index (SDI) and disease activity with the SLEDAI-2K. Univariable and multivariable Cox-regression survival models were carried out to determine the risk of developing new damage. The multivariable model was adjusted for age at diagnosis; disease duration; socioeconomic status; SLEDAI; baseline SDI; the Charlson Comorbidity Index; daily dose; and time of exposure of prednisone (PDN), antimalarials, and immunosuppressive drugs. Two hundred and forty-nine patients were evaluated; 232 of them were women (93.2%). Their mean (SD) age at diagnosis was 35.8 (13.1) years; nearly all patients were Mestizo. Disease duration was 7.4 (6.6) years. The SLEDAI-2K was 5.2 (4.3) and the SDI, 0.9 (1.3). One hundred and eight patients (43.4%) had MetS at baseline. During follow-up, 116 (46.6%) patients accrued at least one new point in the SDI damage index. In multivariable analyses, the presence of MetS was a predictor of the development of new damage (HR: 1.54 (1.05–2.26); p < 0.029). The presence of MetS predicts the development of new damage in SLE patients, despite other well-known risk factors for such occurrence.
- 24 September 2019
- Published by SAGE Publications in Lupus
- Vol. 28 (11) , 1344-1349
Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients
The aim of this study was to determine whether remission and low disease activity state protect systemic lupus erythematosus patients from being hospitalized. Patients from the Almenara Lupus Cohort were included. Visits were performed every 6 months. Variables were measured at each visit. Hospitalizations were evaluated in the interval between two visits. Remission was defined as: a SLEDAI-2 K of 0, prednisone ≤5 mg/day and immunosuppressants on maintenance dose; low disease activity state as: a SLEDAI-2 K of ≤4, prednisone ≤7.5 mg/day and immunosuppressants on maintenance dose. Univariable and multivariable interval-censored survival regression models were used. In multivariable analysis, possible confounders were gender, age at diagnosis, socioeconomic status, educational level, disease duration, antimalarial use, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index (SDI) and Charlson comorbidity index. Confounders were determined in the same visit as disease activity state. Of the 308 patients, 92.5% of them (n = 285) were women, had a mean age at diagnosis of 34.8 (13.4) years and a disease duration of 7.7 (6.5) years. At baseline the mean SDI was 1.13 (1.34). A total of 163 of the patients were hospitalized. In the multivariable analysis remission (hazard ratio 0.445 (0.274–0.725), P = 0.001) and low disease activity state (relative risk 0.504 (0.336–0.757), P = 0.001) at baseline were found to decrease the risk of hospitalization in systemic lupus erythematosus patients. A total of 158 hospitalizations presented a discernible cause. Disease activity was the most common cause of hospitalization, with 84 admissions (53.16%), the majority, 38, was due to active kidney disease (45.23%). Remission and low disease activity state decreased the risk of hospitalizations in these systemic lupus erythematosus patients. Disease activity, particularly renal, was the most frequent cause of hospitalization.
- 24 September 2019
- Published by SAGE Publications in Lupus
- Vol. 28 (11) , 1344-1349
Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients
The aim of this study was to determine whether remission and low disease activity state protect systemic lupus erythematosus patients from being hospitalized. Patients from the Almenara Lupus Cohort were included. Visits were performed every 6 months. Variables were measured at each visit. Hospitalizations were evaluated in the interval between two visits. Remission was defined as: a SLEDAI-2 K of 0, prednisone ≤5 mg/day and immunosuppressants on maintenance dose; low disease activity state as: a SLEDAI-2 K of ≤4, prednisone ≤7.5 mg/day and immunosuppressants on maintenance dose. Univariable and multivariable interval-censored survival regression models were used. In multivariable analysis, possible confounders were gender, age at diagnosis, socioeconomic status, educational level, disease duration, antimalarial use, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index (SDI) and Charlson comorbidity index. Confounders were determined in the same visit as disease activity state. Of the 308 patients, 92.5% of them (n = 285) were women, had a mean age at diagnosis of 34.8 (13.4) years and a disease duration of 7.7 (6.5) years. At baseline the mean SDI was 1.13 (1.34). A total of 163 of the patients were hospitalized. In the multivariable analysis remission (hazard ratio 0.445 (0.274–0.725), P = 0.001) and low disease activity state (relative risk 0.504 (0.336–0.757), P = 0.001) at baseline were found to decrease the risk of hospitalization in systemic lupus erythematosus patients. A total of 158 hospitalizations presented a discernible cause. Disease activity was the most common cause of hospitalization, with 84 admissions (53.16%), the majority, 38, was due to active kidney disease (45.23%). Remission and low disease activity state decreased the risk of hospitalizations in these systemic lupus erythematosus patients. Disease activity, particularly renal, was the most frequent cause of hospitalization.
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 1022-1023
AB0388 A Reduced Lean Body Mass is Associated with a More Severe Joint Damage in Patients with Rheumatoid Arthritis (RA)
Background In Rheumatoid Arthritis (RA) alterations in the amount and distribution of fat and lean mass result in abnormal body composition phenotypes probably as a consequence of persistent inflammatory state. Lower lean mass and the sarcopenia phenotype have been associated with disability previously. Objectives The aim of this study was to determine whether a reduced Lean Body Mass (LBM) is associated with a more severe joint damage in RA Methods A cross-sectional study, conducted in consecutive established RA woman patients seen in our Rheumatology Department between 2012 and 2014. RA was defined using the ACR 1987 criteria. Patients with overlap syndrome (except Sjogren), prosthetic or metallic elements, infections, trauma/ recent surgery, cancer, hospitalized, pregnant or weight>120 kg were excluded. An interview, chart review, physical examination and laboratory tests were performed. All subjects providing written informed consent. LBM was determined by dual X-ray absorptiometry (DXA) and was expressed as the LBM Index (kg/ m2). Joint damage (JD) was measure according to Sharp VD Heijde method (erosion, joint space narrowing and total score). The association between LBM and JD was evaluated using Pearson's correlation. Subsequently, a linear regression model was performed to evaluate the persistence of these association adjusted by age, age at diagnosis, disease duration, Socioeconomic status according to Graffar's scale, tobacco habit, ACPA title, disease activity using the DAS28 ESR, glucocorticoids use and functional capacity (MHAQ questionnaire) Results One hundred and seventy-four women patients were included. The average (SD) age was 57.7 (12.7) years. Disease duration was 14.4 (10.6) years; all patients were mestizo. ACPA title was 768.8 (1357.3) uM/L, DAS28 was 4.8 (1.3), the Sharp VD Heijde total score was 168 (93.6) and the Body Mass Index (BMI) was: 28.19 (4.81) kg/m2. The LBM was 6.03 kg/m2 (0.9) and the percentage of fat Body Mass (FBM) was 38.46 (4.56) In the univariate analysis, according to Pearson correlation Index, a lower LBM was associated with a more total (-0.27, p=0.00); erosion (-0.27, p=0.001) and space narrowing (-0.25, p=0.001) Sharp VDH scores. In the multivariate model adjusted by age, age at diagnosis, disease duration, Graffar's scale, tobacco, ACPA, DAS28, glucocorticoids use and MHAQ, these correlation persisted (erosion score: B: -0.010, p=0.002; space narrowing score: B: -0.012; p=0.002 and total score: B: -0.006 p=0.001) Conclusions A lower Lean Body Mass was associated with a more severe joint damage independently of other risk factors. Strategies aimed at preserving lean muscle mass could have a favorable impact on the course of disease. Disclosure of Interest None declared
- 1 June 2015
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 74 (Suppl 2) , 1022-1023
AB0388 A Reduced Lean Body Mass is Associated with a More Severe Joint Damage in Patients with Rheumatoid Arthritis (RA)
Background In Rheumatoid Arthritis (RA) alterations in the amount and distribution of fat and lean mass result in abnormal body composition phenotypes probably as a consequence of persistent inflammatory state. Lower lean mass and the sarcopenia phenotype have been associated with disability previously. Objectives The aim of this study was to determine whether a reduced Lean Body Mass (LBM) is associated with a more severe joint damage in RA Methods A cross-sectional study, conducted in consecutive established RA woman patients seen in our Rheumatology Department between 2012 and 2014. RA was defined using the ACR 1987 criteria. Patients with overlap syndrome (except Sjogren), prosthetic or metallic elements, infections, trauma/ recent surgery, cancer, hospitalized, pregnant or weight>120 kg were excluded. An interview, chart review, physical examination and laboratory tests were performed. All subjects providing written informed consent. LBM was determined by dual X-ray absorptiometry (DXA) and was expressed as the LBM Index (kg/ m2). Joint damage (JD) was measure according to Sharp VD Heijde method (erosion, joint space narrowing and total score). The association between LBM and JD was evaluated using Pearson's correlation. Subsequently, a linear regression model was performed to evaluate the persistence of these association adjusted by age, age at diagnosis, disease duration, Socioeconomic status according to Graffar's scale, tobacco habit, ACPA title, disease activity using the DAS28 ESR, glucocorticoids use and functional capacity (MHAQ questionnaire) Results One hundred and seventy-four women patients were included. The average (SD) age was 57.7 (12.7) years. Disease duration was 14.4 (10.6) years; all patients were mestizo. ACPA title was 768.8 (1357.3) uM/L, DAS28 was 4.8 (1.3), the Sharp VD Heijde total score was 168 (93.6) and the Body Mass Index (BMI) was: 28.19 (4.81) kg/m2. The LBM was 6.03 kg/m2 (0.9) and the percentage of fat Body Mass (FBM) was 38.46 (4.56) In the univariate analysis, according to Pearson correlation Index, a lower LBM was associated with a more total (-0.27, p=0.00); erosion (-0.27, p=0.001) and space narrowing (-0.25, p=0.001) Sharp VDH scores. In the multivariate model adjusted by age, age at diagnosis, disease duration, Graffar's scale, tobacco, ACPA, DAS28, glucocorticoids use and MHAQ, these correlation persisted (erosion score: B: -0.010, p=0.002; space narrowing score: B: -0.012; p=0.002 and total score: B: -0.006 p=0.001) Conclusions A lower Lean Body Mass was associated with a more severe joint damage independently of other risk factors. Strategies aimed at preserving lean muscle mass could have a favorable impact on the course of disease. Disclosure of Interest None declared